Form 4 Filing for BELITE BIO, INC

On April 27, 2026, MATA NATHAN L., Chief Scientific Officer of BELITE BIO, INC, reported the disposition of 990 shares of American depositary shares. These transactions were executed under a Rule 10b5-1 trading plan. The sales occurred at prices ranging from $160.54 to $164.59 per share. Specifically, 44 shares were sold at a weighted average price of $160.8345, 280 shares at $161.6211, 231 shares at $162.3775, 409 shares at $163.5573, and 36 shares at $164.0717. Following these transactions, MATA NATHAN L. directly owns 7666 shares of American depositary shares.